Skip to content

NVIGEN Inc. vs RareCyte, Inc.

NVIGEN Inc. logo

NVIGEN Inc.

Molecularly Engineered Nanoparticles to Advance Personalized Medicine

11 employees · est. 2011 · San Jose, United States

VS
RareCyte, Inc. logo

RareCyte, Inc.

A one-stop resource for Spatial Biology and Liquid Biopsy solutions

65 employees · est. 2009 · Seattle, United States

RareCyte, Inc. is the older company (2011 vs 2009); RareCyte, Inc. is the larger of the two.

Side-by-Side Comparison

NVIGEN Inc. RareCyte, Inc.
Founded
2011 2009 older
Headquarters
San Jose, United States Seattle, United States
Employees
11 65 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care, Medical Devices
Funding Stage
Series B Venture round
Total Funding
Not tracked yet $96.00M
Funding Rounds
Not tracked yet 6
Services
Precision Medicine Biomarker Profiling, Liquid Biopsy Assays for Cancer, Magnetic Nanoparticle Based Extraction, Protein Capture and Detection Assays Not tracked yet
Target Customers
Biomedical Researchers, Clinical Laboratories, Cancer Research Institutions, Biotech Companies Not tracked yet
Taxonomy
NanobiotechnologyMultifunctional NanoparticlesNanoparticle Imaging Delivery (NID™)Drug Delivery NanoparticlesGenomicsDiagnostics +9 Spatial BiologyLiquid BiopsyRareCytePrecision BiologyOncologyImmuno-oncology +9
Website
nvigen.com rarecyte.com
NVIGEN Inc. logo

About NVIGEN Inc.

NVIGEN Inc., founded in 2011, is a promising player in the biotechnology and health care industries, based in the United States. The company specializes in developing molecularly engineered nanoparticles designed to advance personalized medicine, encapsulated under its slogan: "Molecularly Engineere...

RareCyte, Inc. logo

About RareCyte, Inc.

RareCyte, Inc. is a prominent player in the field of Spatial Biology and Liquid Biopsy solutions, offering a comprehensive range of services to leaders across Research, Translational Medicine, and the Clinic. Headquartered in Seattle, WA, the company has been at the forefront of developing innovativ...

Also comparing in this category

Comparing more than these two?

Get NVIGEN Inc., RareCyte, Inc. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does NVIGEN Inc. compare?

A PDF of NVIGEN Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

NVIGEN Inc. was founded in 2011, based in San Jose, United States, with 11 employees. NVIGEN Inc., founded in 2011, is a promising player in the biotechnology and health care industries, based in the United States. The company specializes in developing molecularly engineered nanopartic. RareCyte, Inc. was founded in 2009, based in Seattle, United States, with 65 employees. RareCyte, Inc. is a prominent player in the field of Spatial Biology and Liquid Biopsy solutions, offering a comprehensive range of services to leaders across Research, Translational Medicine, and the.
NVIGEN Inc. has raised no disclosed funding and RareCyte, Inc. $96.00M. Latest stage: NVIGEN Inc. Series B, RareCyte, Inc. Venture round.
Both work in Biotechnology and Health Care and list liquid biopsy among their focus areas.

Compare NVIGEN Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at NVIGEN Inc. on 24 Mar 2026, and RareCyte, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout